Vascular Surgery Unit, San Giovanni-Addolorata Hospital, Rome, Italy.
Vascular Surgery Unit, University of Bologna and IRCCS Sant'Orsola, Bologna, Italy.
J Vasc Surg. 2024 Dec;80(6):1639-1649. doi: 10.1016/j.jvs.2024.07.090. Epub 2024 Jul 29.
Endovascular repair of complex abdominal aortic aneurysms (CAAAa) and thoracoabdominal aortic aneurysms (TAAAs) with fenestrated and branched devices (F/BEVAR) represents the first-line treatment in old or unfit patients. Currently, the widespread diffusion of these techniques has led to a progressive increase of complex endovascular procedures also in younger and fitter patients, but the related results have been only minimally reported, without long-term data. We investigated the long-term results of F/BEVAR for CAAA and TAAA repair in young and fit patients.
All consecutive patients, aged ≤70 years, who underwent F/BEVAR for CAAA and TAAA over the last 13 years at two tertiary institutions were included in the study. All subjects presented a low to intermediate risk according to the Society for Vascular Surgery clinical comorbidity grading system. The primary end points were technical and clinical success and late overall and aortic-related survival. Major complications and specific target vessel-related outcomes were investigated as secondary end points.
A total of 183 patients (155 males [84.7%]; mean age, 64.5 ± 5.7 years; range, 33-70 years) underwent F/BEVAR during the study period, for a total of 167 degenerative (91.3%) and 16 postdissection (8.7%) aneurysms, including 44 (24%) juxtarenal, 33 (18%) pararenal, and 106 (58%) TAAAs. Technical and clinical success were achieved in 176 patients (96.2%) and 171 patients (93.4%), respectively. Four patients (2.2%) died perioperatively, of which two (1.1%) operated in emergency. Postoperatively, five patients (2.7%) presented permanent grade 3 spinal cord injury and three (1.6%) renal failure needing permanent dialysis. The mean follow-up was 65.7 ± 39.6 months (range, 1-158 months). The estimated overall and aortic-related survival at 12, 60, and 120 months was 94.0%, 85.1%, 72.2%, and 97.8%, 97.8%, 96.2%, respectively, and reintervention and branch instability-free survival at the same time points were 84.4%, 71.8%, 71.8%, and 93.2%, 86.3%, 72.2%, respectively. An aneurysm growth of >5 mm was detected in six patients (3.3%), and a sac shrinkage of >5 mm was achieved in 118 cases (64.5%). The Cox regression analysis demonstrated the need for unplanned procedure as the only risk factor for overall mortality (odds ratio, 3.331; 95% confidence interval, 1.397-7.940; P < .01].
F/BEVAR in young and fit patients led to low perioperative mortality and major morbidity rates and a favorable overall survival rate in the long-term, making this technique particularly appealing in such a subgroup of patients. The availability of long-term data derived from the results of young patients, may additionally provide helpful information to redefine the indications for treatment and allow future targeted device and technique improvements.
对于复杂的腹主动脉瘤(CAAAa)和胸腹主动脉瘤(TAAAs)患者,采用开窗和分支装置(F/BEVAR)的血管内修复术是老年或不适合手术患者的一线治疗方法。目前,这些技术的广泛应用导致了年轻且健康的患者中复杂血管内手术的数量也在逐渐增加,但相关结果仅得到了最小程度的报道,缺乏长期数据。我们研究了 F/BEVAR 在年轻且健康的患者中治疗 CAAA 和 TAAA 的长期结果。
在过去 13 年的两家三级医疗机构中,所有年龄≤70 岁、接受 F/BEVAR 治疗 CAAA 和 TAAA 的连续患者均纳入研究。所有患者均根据血管外科学会临床合并症分级系统被评定为低至中度风险。主要终点是技术和临床成功率以及晚期总体和主动脉相关生存率。主要并发症和特定靶血管相关结局被作为次要终点进行研究。
研究期间共有 183 名患者(155 名男性[84.7%];平均年龄 64.5±5.7 岁;范围 33-70 岁)接受了 F/BEVAR,共涉及 167 例退行性病变(91.3%)和 16 例夹层后病变(8.7%),包括 44 例(24%)肾下型、33 例(18%)肾周型和 106 例(58%)胸腹主动脉瘤。176 名患者(96.2%)和 171 名患者(93.4%)达到了技术和临床成功。4 名患者(2.2%)在围手术期死亡,其中 2 名(1.1%)为急诊手术。术后,5 名患者(2.7%)出现永久性 3 级脊髓损伤,3 名(1.6%)出现需要永久性透析的肾衰竭。平均随访时间为 65.7±39.6 个月(范围 1-158 个月)。12、60 和 120 个月时的总体和主动脉相关生存率估计值分别为 94.0%、85.1%、72.2%和 97.8%、97.8%、96.2%,同期的再干预和分支稳定性无丢失生存率分别为 84.4%、71.8%、71.8%和 93.2%、86.3%、72.2%。6 名患者(3.3%)出现了动脉瘤直径增长>5mm,118 名患者(64.5%)出现了瘤腔直径缩小>5mm。Cox 回归分析表明,需要进行非计划性手术是总体死亡率的唯一危险因素(比值比,3.331;95%置信区间,1.397-7.940;P<.01]。
在年轻且健康的患者中,F/BEVAR 导致了较低的围手术期死亡率和主要发病率,以及长期较好的总体生存率,这使得该技术在该亚组患者中特别有吸引力。从年轻患者的结果中获得的长期数据,可能会额外提供有助于重新定义治疗适应证的信息,并允许未来进行有针对性的设备和技术改进。